Aβ aggregation-IN-2

Aβ aggregation-IN-2 (Compound 8i) is an inhibitor of amyloid β-protein (Aβ42) aggregation, demonstrating an approximate 91% inhibition rate at 25 μM. It also possesses the ability to induce Aβ42 depolymerization and exhibits antioxidant activity. Aβ aggregation-IN-2 is applicable in Alzheimer's disease research.